Influence of liver disease on phenolsulfonphthalein absorption from liver surface to examine possibility of direct liver surface application for drug targeting

Biological and Pharmaceutical Bulletin

Volumn 26, Issue 7, 2003, Pages 988-993

  Nishida, Koyo ^a   Honda, Tominori ^a   Nakashima, Mikiro ^a   Sasaki, Hitoshi ^a   Nakamura, Junzo ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Absorption; Drug targeting; Liver disease; Organ surface

Indexed keywords

CARBON TETRACHLORIDE; GALACTOSAMINE; PHENOLSULFONPHTHALEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; COMPARTMENT MODEL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BILE LEVEL; DRUG BLOOD LEVEL; DRUG EXCRETION; DRUG TARGETING; DRUG URINE LEVEL; FIRST PASS EFFECT; LIVER DISEASE; LIVER MEMBRANE; MALE; MOLECULAR WEIGHT; NONHUMAN; RAT; ABSORPTION; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG DELIVERY SYSTEM; DRUG EFFECT; IN VITRO STUDY; INTOXICATION; LIVER; METABOLISM; METHODOLOGY; PHYSIOLOGY; WISTAR RAT;

ABSORPTION; ANIMALS; CARBON TETRACHLORIDE POISONING; DRUG DELIVERY SYSTEMS; LIVER; LIVER DISEASES; MALE; PHENOLSULFONPHTHALEIN; RATS; RATS, WISTAR;

EID: 1542602475     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.26.988     Document Type: Article

References (29)

1. Nishida K., Sato N., Sasaki H., Nakamura J., J. Pharm. Pharmacol., 46, 867-870 (1994).
2. Nishida K., Sato N., Sasaki H., Nakamura J., J. Pharm. Pharmacol., 47, 227-231 (1995).
3. Nishida K., Sato N., Sasaki H., Nakamura J., Biol. Pharm. Bull., 18, 1548-1550 (1995).
4. Nishida K., Amagishi H., Sasaki H., Nakamura J., J. Pharm. Pharmacol., 47, 1032-1035 (1995).
5. Nishida K., Sato N., Sasaki H., Nakamura J., J. Drug Target., 4, 141- 150 (1996).
6. Nishida K., Sato N., Nakakoga Y., Mukai T., Sasaki H., Nakamura J., J. Pharm. Pharmacol., 49, 976-980 (1997).
7. Nishida K., Yoshida Y., Mukai T., Kawakami S., Sakaeda T., Nakashima M., Sasaki H., Nakamura J., J. Pharm. Pharmacol., 53, 1341-1346 (2001).
8. Kawakami S., Hirayama R., Shoji K., Kawanami R., Nishida K., Nakashima M., Sasaki H., Sakaeda T., Nakamura J., Biochem. Biophys. Res. Commun., 294, 46-50 (2002).
9. Hepp K. D., Diabetologia, 37 (Suppl. 2), S108-S111 (1994).
10. Stellato T. A., Surg. Clin. North Am., 72, 997-1002 (1992).
11. Nagy J. A., Herzberg K. T., Masse E. M., Zientara G. P., Dvorak H. F., Cancer Res., 49, 5448-5458 (1989).
12. Shostak A., Gotloib L., Kidney Int., 49, 705-714 (1996).
13. Balthasar J. P., Fung H. L., Life Sci., 58, 535-543 (1996).
14. Dedrick R. L., Flessner M. F., J. Natl. Cancer Inst., 89, 480-487 (1997).
15. Iga T., Yokota M., Sugiyama Y., Awazu S., Hanano M., Biochem. Pharmacol., 29, 1291-1297 (1980).
16. Kimura T., Nakayama S., Yamao T., Kurosaki Y., Nakayama T., Biol. Pharm. Bull., 16, 1140-1145 (1993).
17. Ishida S., Sakiya Y., Ichikawa T., Taira Z., Awazu S., J. Pharmacobio-Dyn., 13, 142-157 (1990).
18. Wang Z., Okamoto M., Kurosaki Y., Nakayama T., Kimura T., Biol. Pharm. Bull., 19, 901-904 (1996).
19. Yasuhara M., Katayama H., Fujiwara J., Okumura K., Hori R., J. Pharmacobio-Dyn., 8, 377-384 (1985).
20. Nishida K., Tonegawa C., Kakutani T., Hashida M., Sezaki H., Pharm. Res., 6, 140-146 (1989).
21. Kakutani T., Endo K., Nara E., Nakazora S., Hashida M., Pharm. Res., 9, 908-914 (1992).
22. Hart L. G., Schanker L. S., Proc. Soc. Exp. Biol. Med., 123, 433-435 (1966).
23. Yamaoka K., Nakagawa T., Uno T., J. Pharmacokinet. Biopharm., 6, 547-558 (1978).
24. Yamaoka K., Tanigawara Y., Nakagawa T., Uno T., J. Pharmacobio-Dyn., 4, 879-885 (1981).
25. Keppler D., Lesch R., Reutter W., Decker K., Exp. Mol. Pathol., 9, 279-290 (1968).
26. Keppler D., Rudigier J., Reutter W., Lesch R., Decker K., Hoppe Seylers Z. Physiol. Chem., 351, 102-104 (1970).
27. Makin A. J., Hughes R. D., Williams R., Am. J. Physiol., 272, G617-G625 (1997).
28. Sugihara N., Furuno K., Kita N., Murakami T., Yata N., Chem. Pharm. Bull., 40, 2516-2519 (1992).
29. Schanker L. S., Tocco D. J., Brodie B. B., Hogben C. A. M., J. Pharmacol. Exp. Ther., 123, 81-88 (1958).